EFTA01199043.pdf

From: Trivia Smith ‹. .s To: [email protected] Cc: Mortis c Nay Gupta •-• >, Vinit Sahni Vahe Stepanian Subject: S/Y and Biotech ICI Date: Wed, 23 Apr 2014 15:54:05 +0000 Attachments: I 82298_20140422_20140423_Lpdf Inline-Images: unnamed; unnamed(I); unnamed(2); unnamed(3); unnamed(4) Classificabcn: Confidential Jeffrey - Just posting you on your biotech basket - earnings a positive catalyst reversing that downtrend n Gilead. Bingen reported this momig (bottom line miss. top-me beat), stock has come in from pre-market highs of $310. now —$303 (3-day chart below). Just a reminder that your SY 102.5 call is going to expire 5/1. In speaking with Nay and Vint, they looked at lot of weaker-yen iterations but their view is vols are too low and there is an absence of catalysts to present a compelling trade at this moment to roll into: Nav will email you directly to highlight entry pcints on a trade when he sees one. As you know. you've got your zero-cost option on for some exposure to yen weakness. As of 4/23/1411:34 pm IDX_LAst Description Trade Date Quantity Current Price Unit Cost Market Value Current Total Cost Unrealized G/L SANGAMO BIOSCIENCES 5/28/2013 50,000.00 S 14.17 8.44 S 708,500.00 422,214.00 $ 286,286.00 BIOGEN 2/14/2012 2,095.00 $ 300.61 5 119.55 $ 629,786.33 250,454.95 $ 379,331.38 FOUNDATION MEDICINE 1/13/2014 25,000.00 $ 26.74 27.51 $ 668,500.00 687,663.50 $ (19.163.50) GILEAD SCIENCES INC Multiple 8,100.00 $ 74.93 S 79.41 5 606,932.19 643,204.00 $ (36,271.81) ARIAD PHARMACEUTICALS Multiple 16,535.00 $ 7.58 $ 17.60 $ 125,333.65 290,997.40 $ (165,663.75) Total Biotech $ 2,739,052.17 $ 2.294.533.85 $ 444,518.32 urce: Pershing. LLC and Bloomberg As of 4/22/14 the Description Trade Date Expiration Notional Cost Basis my' WM. PA USDWY Triple One-Touch 101Call 11/21/2013 11/20/2014 1,000,000 USD r $ - $ 5,189 $ 5,189 USW eV 102.5 Call 1/31/2014 5/1/2014 10,000,000 USD $190,000 $ 49,749 $ (140,251) Dec14 Copper 7000 Call 4/7/2014 12/3/2014 1,250 metric tons $331,250 $ 290,500 $ (40,750) 1 $521,250 $ 34SA38 $ 11.75,t121 • Not a bid/offer. Mid Mark-to-Market as reported on client s DES Valuation Statement. Closed initbl Trade Unwind Unwind Description Date Trade Date Cost Basis Value P/I. USDCAD RKI Call Spread 1/17/2014 3/5/2014 $109,995 $ 115,000 $ 5,005 USDRUB 37.595 Binary 3/13/2014 4/14/2014 1,000,000uSD $257,000 $ - $ (257,003) Jun14 WTI 101/93.50 Risk Reversal 3/13/2014 5/15/2014 100,000 bbls $ • $ 312,000 $ 312,000 $ 60,00S Biogen 3-day inter-day chart EFTA01199043  MB US 1301.96 -4.24 r— 'The Q302.26/302.903 3x3 11:43 Vol 1 084 063 0309.00P P 311.10D L295.498 Val 327.768M 04 21 2014 04 23 2014 gap Trade CPMI;O:( ID 10 III 611 D IV max Tick V c eSeicirity/Sta NOt 191I : Track .7 Annotate to News D. Zoom 315 : I • 8118 US Equity 301.96 • Goan on 04/17 ---- 289.99 I High an 04/23 08:03 31325 -9- Average 302.6895 I. Low on 09/21 09:38 290.20 12:00 21 Apr 2014 22 kr 2014 Tazia Smith Diectet I Key Chord US DO &collies int peutieheAssel Wealth Manstement Ravio-KilyPeepoft This communication may contain confidential and/or privileged information. If you are not the intended recipient for have received this communication in error) please notify the sender immediately and destroy this communication. Any unauthorized copying, disclosure or distribution of the material in this communication is strictly forbidden. Deutsche Bank does not render legal or tax advice, and the information contained in this communication should not be regarded as such. EFTA01199044